Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 1;69(4):621-634.
doi: 10.2478/acph-2019-0054.

In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

Bisera Jurišić Dukovski  1 , Ana Bračko  1 , Marija Šare  1 , Ivan Pepić  1 , Jasmina Lovrić  1
Affiliations
Free article

In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

Bisera Jurišić Dukovski et al. Acta Pharm. .
Free article

Abstract

Oil-in-water nanoemulsions (NEs) represent one of the formulation approaches to improve eye-related bio-availability of lipophilic drugs. The potential of cationic NEs is pronounced due to the electrostatic interaction of positively charged droplets with negatively charged mucins present in the tear film, providing prolonged formulation residence at the ocular surface. The aim of this study was to develop a cationic ophthalmic NE with cationic lipid stearylamine (SA) as a carrier of a positive charge. The addition of a nonionic surfactant provided the dual electro-steric stabilization of NEs and enabled tuning of SA concentration to achieve an optimal balance between its interaction with mucins and biocompatibility. Physicochemical characterization, stability profile, in vitro mucoadhesion study and biocompatibility study employing 3D HCE-T cell-based model of corneal epithelium pointed out the NE with 0.05 % (m/m) SA as the leading formulation. Minimizing SA content while retaining droplet/mucin interactions is of great importance for efficacy and safety of future ophthalmic drug products.

Keywords: biocompatibility; cationic nanoemulsions; mucoadhesion in vitro; ophthalmic drug delivery; stearylamine.

PubMed Disclaimer

References

REFERENCES

    1. 1. S. Tamilvanan and S. Benita, The potential of lipid emulsion for ocular delivery of lipophilic drugs, Eur. J. Pharm. Biopharm.58 (2004) 357–368; https://doi.org/10.1016/J.EJPB.2004.03.03310.1016/j.ejpb.2004.03.033
    1. 2. F. Lallemand, P. Daull, S. Benita, R. Buggage and J.-S. Garrigue, Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb, J. Drug Deliv.2012 (2012) 604204; https://doi.org/10.1155/2012/60420410.1155/2012/604204
    1. 3. L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang, F. Eperjesi, J. Liu and Y. Gan, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov. Today18 (2013) 290–297; https://doi.org/10.1016/J.DRUDIS.2012.10.00510.1016/j.drudis.2012.10.005
    1. 4. C. Maïssa, M. Guillon, P. Simmons and J. Vehige, Effect of castor oil emulsion eyedrops on tear film composition and stability, Contact Lens Anterior Eye33 (2010) 76–82; https://doi.org/10.1016/j.clae.2009.10.00510.1016/j.clae.2009.10.005
    1. 5. A. Manosroi, K. Podjanasoonthon and J. Manosroi, Development of novel topical tranexamic acid liposome formulations, Int. J. Pharm.235 (2002) 61–70; https://doi.org/10.1016/S0378-5173(01)00980-210.1016/S0378-5173(01)00980-2

MeSH terms

LinkOut - more resources